Activation of PPAR‐α in streptozotocin‐induced diabetes is essential for resistance against acetaminophen toxicity
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Diabetic (DB) mice exhibit significant resistance to hepatotoxicants. The role of peroxisome proliferator receptor (PPAR)‐α activation in diabetes, in protection against lethal acetaminophen (APAP) challenge, was investigated. Upon treatment with APAP (600 mg/kg, i.p., a LD 100 dose in wild‐type [WT] non‐DB mice), WT‐DB mice showed only 30% mortality and 40% less liver injury as measured by alanine aminotransferase and histopathology. In contrast, diabetes in PPAR knockout (PPAR‐α −/− ) mice failed to protect against APAP toxicity, suggesting the importance of PPAR‐α in diabetes‐induced protection. S‐phase DNA synthesis and PCNA immunohistochemical staining after injury showed early and robust tissue repair in WT‐DB mice, but not in the PPAR‐α −/− ‐DB mice. Microarray analyses were performed on livers from non‐DB and DB (WT and PPAR‐α −/− ) mice at 0 and 12 h after APAP. Microarray data were confirmed via real‐time polymerase chain reaction analysis of several genes, including stress response, immediate early genes, DNA damage, heat shock proteins, and cell cycle regulators, followed by Western analyses of selected proteins. Gel shift assays revealed higher activation of nuclear factor‐κB in WT‐DB mice after APAP treatment. These findings suggest PPAR‐α activation as a hepatoprotective adaptive response mediating protection against APAP in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michalik, L., Desvergne, B., Tan, N. S., Basu-Modak, S., Escher, P., Rieusset, J., Peters, J. M., Kaya, G., Gonzalez, F. J., Zakany, J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200011148 · Cited by 406
Cited by
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Self-citationRole of peroxisome proliferator-activated receptor-α in fasting-mediated oxidative stress
Abdelmegeed, M. A., Moon, K.-H., Hardwick, J. P., Gonzalez, F. J., & Song, B.-J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.017 · Cited by 74
Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
P. Menendez-Gutierrez, M., Roszer, T., & Ricote, M. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436669 · Cited by 62
“In diabetic mice, the increased PPAR expression in liver might account for increased gluconeogenesis [86].”
Background
Metadata
- Authors
- Shankar, K., Vaidya, V. S., Christopher Corton, J., Bucci, T. J., Liu, J., Waalkes, M. P., & Mehendale, H. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-07-18
- Volume
- 17
- Issue
- 12
- Pages
- 1748-1750
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2131533678
- Cited by
- 60
- References
- 1
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of PPAR‐α in streptozotocin‐induced diabetes is essential for resistance against acetaminophen toxicity. https://app.cochat.ai/papers/10.1096/fj.02-1186fje
- The paper
- Shankar, K., Vaidya, V. S., Christopher Corton, J., Bucci, T. J., Liu, J., Waalkes, M. P., & Mehendale, H. M. (2003). Activation of PPAR‐α in streptozotocin‐induced diabetes is essential for resistance against acetaminophen toxicity. The FASEB Journal. https://doi.org/10.1096/fj.02-1186fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.